Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Lassa fever is a significant health threat to West African human populations with hundreds of thousands of annual cases. There are no approved medical countermeasures currently available. Compassionate use of the antiviral drug ribavirin or transfusion of convalescent serum has resulted in mixed suc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antiviral Res
Päätekijät: Cross, Robert W, Mire, Chad E, Branco, Luis M, Geisbert, Joan B, Rowland, Megan M., Heinrich, Megan L., Goba, Augustine, Momoh, Mambu, Grant, Donald S, Fullah, Mohamed, Khan, Sheik Humarr, Robinson, James E, Geisbert, Thomas W, Garry, Robert F
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5032844/
https://ncbi.nlm.nih.gov/pubmed/27531367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.08.012
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia